These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 26069201)

  • 1. The clinical translational potential of p53-related alterations as cancer biomarkers.
    Xiao M; Wang X; Chen W
    Histol Histopathol; 2015 Oct; 30(10):1171-83. PubMed ID: 26069201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
    Cai S; Han K
    J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas.
    Köbel M; Reuss A; du Bois A; Kommoss S; Kommoss F; Gao D; Kalloger SE; Huntsman DG; Gilks CB
    J Pathol; 2010 Oct; 222(2):191-8. PubMed ID: 20629008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway.
    Jiang W; Zhao S; Jiang X; Zhang E; Hu G; Hu B; Zheng P; Xiao J; Lu Z; Lu Y; Ni J; Chen C; Wang X; Yang L; Wan R
    Cancer Lett; 2016 Feb; 371(2):314-25. PubMed ID: 26683776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the potential of p53 isoforms as a predictive biomarker in the treatment of cancer?
    Hayman L; Chaudhry WR; Revin VV; Zhelev N; Bourdon JC
    Expert Rev Mol Diagn; 2019 Feb; 19(2):149-159. PubMed ID: 30582376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z
    Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
    Edamoto Y; Hara A; Biernat W; Terracciano L; Cathomas G; Riehle HM; Matsuda M; Fujii H; Scoazec JY; Ohgaki H
    Int J Cancer; 2003 Sep; 106(3):334-41. PubMed ID: 12845670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of serum hCG beta and p53 tissue expression defines distinct subgroups of serous ovarian carcinoma.
    Vartiainen J; Lassus H; Lehtovirta P; Finne P; Alfthan H; Butzow R; Stenman UH
    Int J Cancer; 2008 May; 122(9):2125-9. PubMed ID: 18098286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective Biomarkers and Radiation Treatment in Head and Neck Cancer.
    Ow TJ; Pitts CE; Kabarriti R; Garg MK
    Arch Pathol Lab Med; 2015 Nov; 139(11):1379-88. PubMed ID: 26046489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma.
    Cho DS; Joo HJ; Oh DK; Kang JH; Kim YS; Lee KB; Kim SJ
    Yonsei Med J; 2005 Feb; 46(1):133-40. PubMed ID: 15744816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.
    Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK
    Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between p53 and epidermal growth factor receptor expression in breast cancer classification.
    Wang XZ; Liu Q; Sun JJ; Zuo WS; Hu DW; Ma SG; Mu DB; Yu ZY
    Genet Mol Res; 2015 Apr; 14(2):4282-90. PubMed ID: 25966200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of O-Linked Glycoproteins Binding to the Lectin Helix pomatia Agglutinin as Markers of Metastatic Colorectal Cancer.
    Peiris D; Ossondo M; Fry S; Loizidou M; Smith-Ravin J; Dwek MV
    PLoS One; 2015; 10(10):e0138345. PubMed ID: 26495974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in p53 research: an interdisciplinary perspective.
    Olivier M; Petitjean A; Marcel V; Pétré A; Mounawar M; Plymoth A; de Fromentel CC; Hainaut P
    Cancer Gene Ther; 2009 Jan; 16(1):1-12. PubMed ID: 18802452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 is not a prognostic marker-clinical consequences of a generally disregarded fact.
    Braunschmid T; Kührer I; Mittlböck M; Westerhoff M; Kappel-Latif S; Brammen L; Krishnadath KK; Phillips WA; Gnant M; Kandioler D
    Ann N Y Acad Sci; 2018 Dec; 1434(1):46-53. PubMed ID: 30112858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 Isoform Delta113p53 in zebrafish.
    Chen J; Peng J
    Zebrafish; 2009 Dec; 6(4):389-95. PubMed ID: 19916829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer.
    Batchu RB; Gruzdyn OV; Qazi AM; Kaur J; Mahmud EM; Weaver DW; Gruber SA
    Surgery; 2015 Oct; 158(4):981-6; discussion 986-7. PubMed ID: 26189069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive and prognostic cancer biomarkers revisited.
    Pritzker KP
    Expert Rev Mol Diagn; 2015; 15(8):971-4. PubMed ID: 26134385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53: a heavily dictated dictator of life and death.
    Lu X
    Curr Opin Genet Dev; 2005 Feb; 15(1):27-33. PubMed ID: 15661530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients.
    Nagai Y; Yamamoto Y; Yasuhara T; Hata K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Yamanaka T; Miyagawa K; Watanabe T
    Oncotarget; 2015 Aug; 6(25):21064-73. PubMed ID: 26046797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.